Session

IBD (Posters)

INVESTIGATION OF SOMATIC MUTATIONS IN BIOPSIES FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE
INVESTIGATION OF SOMATIC MUTATIONS IN BIOPSIES FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

OPIOID EXPOSURE IN IBD AND ASSOCIATED FACTORS: A UK PROSPECTIVE MULTICENTRE AUDIT OF 1362 PATIENTS
OPIOID EXPOSURE IN IBD AND ASSOCIATED FACTORS: A UK PROSPECTIVE MULTICENTRE AUDIT OF 1362 PATIENTS

IBD (Posters)  et al.

EFFECTIVENESS OF POLYMERIC EXCLUSIVE ENTERAL NUTRITION AS AN ADJUNCT TO STANDARD OF CARE IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
EFFECTIVENESS OF POLYMERIC EXCLUSIVE ENTERAL NUTRITION AS AN ADJUNCT TO STANDARD OF CARE IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

IBD (Posters)  et al.

CLAUDIN-2 OVEREXPRESSION IN STEM CELL ZONE CORRELATES WITH INCREASED INTESTINAL PERMEABILITY AND EPITHELIAL CELL PROLIFERATION DURING SHORT RECOVERY PERIOD IN ACUTE MURINE DSS MODEL OF INFLAMMATORY BOWEL DISEASE
CLAUDIN-2 OVEREXPRESSION IN STEM CELL ZONE CORRELATES WITH INCREASED INTESTINAL PERMEABILITY AND EPITHELIAL CELL PROLIFERATION DURING SHORT RECOVERY PERIOD IN ACUTE MURINE DSS MODEL OF INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

PREHABILITATION STRATEGIES PRIOR TO ILEOCOLIC (RE-)RESECTION IN PATIENTS WITH CROHN’S DISEASE: A MISSED WINDOW OF OPPORTUNITY?
PREHABILITATION STRATEGIES PRIOR TO ILEOCOLIC (RE-)RESECTION IN PATIENTS WITH CROHN’S DISEASE: A MISSED WINDOW OF OPPORTUNITY?

IBD (Posters)  et al.

COMPARISON OF CLINICAL IMPROVEMENT AS MEASURED BY TWO QUALITY-OF-LIFE INDEXES: A POOLED ANALYSIS OF VEDOLIZUMAB RANDOMIZED CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE
COMPARISON OF CLINICAL IMPROVEMENT AS MEASURED BY TWO QUALITY-OF-LIFE INDEXES: A POOLED ANALYSIS OF VEDOLIZUMAB RANDOMIZED CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

THE BENEFICIAL EFFECTS OF INCREASING DIETARY FIBER CONSUMPTION ON CLINICAL FLARE AND INFLAMMATORY MARKERS AMONG PATIENTS WITH CLINICALLY QUIESCENT INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE LONGITUDINAL STUDY
THE BENEFICIAL EFFECTS OF INCREASING DIETARY FIBER CONSUMPTION ON CLINICAL FLARE AND INFLAMMATORY MARKERS AMONG PATIENTS WITH CLINICALLY QUIESCENT INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE LONGITUDINAL STUDY

IBD (Posters)  et al.

IDENTIFICATION OF A DISTINCT MICROBIOTA SIGNATURE IN CROHN’S DISEASE-ASSOCIATED AND CRYPTOGLANDULAR PERIANAL FISTULAS
IDENTIFICATION OF A DISTINCT MICROBIOTA SIGNATURE IN CROHN’S DISEASE-ASSOCIATED AND CRYPTOGLANDULAR PERIANAL FISTULAS

IBD (Posters)  et al.

USE OF FAECAL CALPROTECTIN AS A PROGNOSTIC MARKER OF RESPONSE TO TREATMENT WITH FILGOTINIB: POST HOC ANALYSIS FROM THE SELECTION STUDY
USE OF FAECAL CALPROTECTIN AS A PROGNOSTIC MARKER OF RESPONSE TO TREATMENT WITH FILGOTINIB: POST HOC ANALYSIS FROM THE SELECTION STUDY

IBD (Posters)  et al.

MEASURING ADALIMUMAB AND INFLIXIMAB TROUGH LEVELS FROM FINGER PRICK BLOOD WITH A RAPID POINT-OF-CARE ASSAY
MEASURING ADALIMUMAB AND INFLIXIMAB TROUGH LEVELS FROM FINGER PRICK BLOOD WITH A RAPID POINT-OF-CARE ASSAY

IBD (Posters)  et al.

SERUM PROTEOME PROFILES IN CROHN’S DISEASE PATIENTS WITH DIFFERENT PHENOTYPES TOWARDS BIOMARKER IDENTIFICATION
SERUM PROTEOME PROFILES IN CROHN’S DISEASE PATIENTS WITH DIFFERENT PHENOTYPES TOWARDS BIOMARKER IDENTIFICATION

IBD (Posters)  et al.

POOR SLEEP IN IBD IS ASSOCIATED WITH ACTIVE DISEASE, ANXIETY AND DEPRESSION, AND OUTCOMES SUCH AS INCREASED FATIGUE, INCREASED DISABILITY, AND POOR QUALITY OF LIFE
POOR SLEEP IN IBD IS ASSOCIATED WITH ACTIVE DISEASE, ANXIETY AND DEPRESSION, AND OUTCOMES SUCH AS INCREASED FATIGUE, INCREASED DISABILITY, AND POOR QUALITY OF LIFE

IBD (Posters)  et al.

PERSONALISED AZITHROMYCIN+METRONIDAZOLE (PAZAZ), IN COMBINATION WITH STANDARD INDUCTION THERAPY, TO ACHIEVE A FAECAL MICROBIOME COMMUNITY STRUCTURE AND METAGENOME CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PAEDIATRIC CROHN’S DISEASE (CD): INITIAL RESU
PERSONALISED AZITHROMYCIN+METRONIDAZOLE (PAZAZ), IN COMBINATION WITH STANDARD INDUCTION THERAPY, TO ACHIEVE A FAECAL MICROBIOME COMMUNITY STRUCTURE AND METAGENOME CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PAEDIATRIC CROHN’S DISEASE (CD): INITIAL RESU

IBD (Posters)  et al.

EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY FOR CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS
EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY FOR CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS

IBD (Posters)  et al.

NEW-ONSET INFLAMMATORY BOWEL DISEASE DURING TREATMENT WITH THE ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY SECUKINUMAB. A CASE SERIES PRESENTATION
NEW-ONSET INFLAMMATORY BOWEL DISEASE DURING TREATMENT WITH THE ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY SECUKINUMAB. A CASE SERIES PRESENTATION

IBD (Posters)  et al.

TOWARDS A PERSONALIZED APPROACH IN ULCERATIVE COLITIS: ROLE OF OCTN1 IN PREDICTING DISEASE SEVERITY AND INDIVIDUAL RESPONSE TO THERAPY
TOWARDS A PERSONALIZED APPROACH IN ULCERATIVE COLITIS: ROLE OF OCTN1 IN PREDICTING DISEASE SEVERITY AND INDIVIDUAL RESPONSE TO THERAPY

IBD (Posters)  et al.

OUTCOME PREDICTORS FOR VEDOLIZUMAB THERAPY IN CROHN’S DISEASE PATIENTS IN A REAL-WORLD SETTING
OUTCOME PREDICTORS FOR VEDOLIZUMAB THERAPY IN CROHN’S DISEASE PATIENTS IN A REAL-WORLD SETTING

IBD (Posters)  et al.

SALIVARY EXOSOMES AGGRAVATE COLITIS BY REGULATING THE GUT IMMUNITY
SALIVARY EXOSOMES AGGRAVATE COLITIS BY REGULATING THE GUT IMMUNITY

IBD (Posters)  et al.

FISTULOUS SKIN METASTASES IN CROHN'S DISEASE: A CASE REPORT AND REVIEW OF THE LITERATURE
FISTULOUS SKIN METASTASES IN CROHN'S DISEASE: A CASE REPORT AND REVIEW OF THE LITERATURE

IBD (Posters)  et al.

ARTIFICIAL INTELLIGENCE IN HISTOPATHOLOGICAL DIAGNOSIS OF IBD – A PILOT STUDY
ARTIFICIAL INTELLIGENCE IN HISTOPATHOLOGICAL DIAGNOSIS OF IBD – A PILOT STUDY

IBD (Posters)  et al.

Item 541 - 560 / 612
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
28
29 30 31